Imprinted tumor suppressor gene ARHI induces apoptosis correlated with changes in DNA methylation in pancreatic cancer cells

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 581-587

  Yang, Hong ^a   Lu, Xingqing ^a   Qian, Jiaming ^a   Xu, Fengji ^b   Hu, Yiqun ^a   Yu, Yinhua ^c   Bast, Robert C ^d   Li, Jingnan ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b Peking Hemujia Hospital   (China)

^c FUDAN UNIVERSITY   (China)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; DNA methylation; Pancreatic cancer; Ras homolog member I

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; APLESIA RAS HOMOLOGUE MEMBER I; MESSENGER RNA; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOUSE; NICK END LABELING; NONHUMAN; NUDE MOUSE; PANCREAS CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT;

MUS; MUS MUSCULUS;

EID: 77956670560     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000301     Document Type: Article

References (22)

1. Smakman N, Borel Rinkes IH, Voest EE and Kranenburg O: Control of colorectal metastasis formation by K-Ras. Biochim Biophys Acta 1756: 103-114, 2005. (Pubitemid 41773137)
2. Kranenburg O: The KRAS oncogene: past, present, and future. Biochim Biophys Acta 1756: 81-82, 2005.
3. Schubbert S, Shannon K and Bollag G: Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 7: 295-308, 2007. (Pubitemid 46480970)
4. Hingorani SR, Petricoin EF, Maitra A, et al: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450, 2003.
5. Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, Horner J, Redston MS and DePinho RA: Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 17: 3112-3126, 2003. (Pubitemid 38040774)
6. Deramaudt T and Rustgi AK: Mutant KRAS in the initiation of pancreatic cancer. Biochim Biophys Acta 1756: 97-101, 2005. (Pubitemid 41773136)
7. Bourne HR, Sanders DA and McCormick F: The GTPase superfamily: conserved structure and molecular mechanism. Nature 349: 117-127, 1991.
8. Bos JL: ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989. (Pubitemid 19213607)
9. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y, Cuevas B, Kuo WL, Gray JW, Siciliano M, Mills GB and Bast RC Jr: NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas. Proc Natl Acad Sci USA 96: 214-219, 1999. (Pubitemid 29036079)
10. Xu F, Xia W, Luo RZ, Peng H, Zhao S, Dai J, Long Y, Zou L, Le W, Liu J, Parlow AF, Hung MC, Bast RC Jr and Yu Y: The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice. Cancer Res 60: 4913-4920, 2000.
11. Shi Z, Zhou X, Xu L, Zhang T, Hou Y, Zhu W and Zhang T: NOEY2 gene mRNA expression in breast cancer tissue and its relation to clinicopathological parameters. Zhonghua Zhong Liu Za Zhi 24: 475-478, 2002.
12. Bao JJ, Le XF, Wang RY, Yuan J, Wang L, Atkinson EN, LaPushin R, Andreeff M, Fang B, Yu Y and Bast RC Jr: Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Cancer Res 62: 7264-7272, 2002. (Pubitemid 36025248)
13. Lu Z, Luo RZ and Khare S: Inducible expression of tumor suppressor gene ARHI in ovarian cancer cells triggers G2M arrest and inhibits cancer cell growth in vitro and in vivo. Proc Am Assoc Cancer Res 46: 2895, 2005.
14. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, Kondo S, Kondo Y, Yu Y, Mills GB, Liao WS and Bast RC Jr: The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 118: 3917-3929, 2008.
15. Yu Y, Luo R, Lu Z, Feng W, Badgwell D, Issa JP, Rosen DG, Liu J and Bast RC Jr: Biochemistry and biology of ARHI (DIRAS3), an imprinted tumor suppressor gene whose expression is lost in ovarian and breast cancers. Methods Enzymol 407: 455-468, 2006. (Pubitemid 43815969)
16. Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS, Yu Y and Bast RC Jr: ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers. Oncogene 22: 2897-2909, 2003. (Pubitemid 36648916)
17. Luo RZ, Peng H, Xu F, Bao J, Pang Y, Pershad R, Issa JP, Liao WS, Bast RC Jr and Yu Y: Genomic structure and promoter characterization of an imprinted tumor suppressor gene ARHI. Biochim Biophys Acta 1519: 216-222, 2001. (Pubitemid 32545431)
18. Yuan J, Luo RZ, Fujii S, Wang L, Hu W, Andreeff M, Pan Y, Kadota M, Oshimura M, Sahin AA, Issa JP, Bast RC Jr and Yu Y: Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers. Cancer Res 63: 4174-4180, 2003. (Pubitemid 36917943)
19. Lu X, Qian J, Yu Y, Yang H and Li J: Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest. Oncol Rep 22: 635-640, 2009.
20. Baylin SB and Ohm JE: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116, 2006.
21. Sato N and Goggins M: The role of epigenetic alterations in pancreatic cancer. J Hepatobiliary Pancreat Surg 13: 286-295, 2006.
22. Ghaneh P, Costello E and Neoptolemos JP: Biology and management of pancreatic cancer. Gut 56: 1134-1152, 2007.